Alkermes (ALKS) Income from Non-Controlling Interests (2011 - 2013)
Alkermes' (ALKS) quarterly Income from Non-Controlling Interests came in at $735000.0 in Q4 2013, up 23.74% quarter-over-quarter from $594000.0 in Q3 2012.
Powered by 
Analysis
Alkermes (ALKS) Income from Non-Controlling Interests (2011 - 2013) Analysis & Trends
Alkermes (ALKS) has reported Income from Non-Controlling Interests for 3 consecutive years, with $735000.0 the latest figure, recorded in Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.32 Bn | 623.56 Bn | 17.26 Bn | - |
| 2 | AbbVie | 440.60 Bn | 434.04 Bn | 12.70 Bn | 3.00 Mn |
| 3 | Merck | 365.39 Bn | 358.25 Bn | 12.21 Bn | -2.00 Mn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -7.00 Mn |
| 5 | Pfizer | 159.22 Bn | 147.52 Bn | 10.94 Bn | 10.00 Mn |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn | 39.52 Mn |
| 7 | Revolution Medicines | 44.21 Bn | 44.21 Bn | - | - |
| 8 | Incyte | 25.34 Bn | 20.81 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.49 Bn | 18.82 Bn | 683.80 Mn | - |
| 10 | Alkermes | 7.58 Bn | 6.93 Bn | 397.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2013 | 735,000.00 |
| Sep 30, 2012 | 594,000.00 |
| Sep 30, 2011 | -244,000.00 |